Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutationZhuanyun Du, Ningshu Huang|Experimental Hematology and Oncology|2022Cited by 40